Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scholar Rock Holding Corp (DE:2QK)
BERLIN:2QK
RESEARCH TOOLSreports
Scholar Rock Holding (2QK) Stock Price & Analysis
0 Followers
2QK Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€5.35 - €18.30
Previous Close€13.9
Volume0.00
Average Volume (3M)523.00
Market Cap
€1.14B
Enterprise Value€932.95M
Total Cash (Recent Filing)$279.94M
Total Debt (Recent Filing)$61.82M
Price to Earnings (P/E)N/A
Beta1.16
Next Earnings
May 09, 2024EPS Estimate
-€0.45Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding77,866,281
10 Day Avg. Volume2
30 Day Avg. Volume523
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)5.31
Price to Sales (P/S)1339.30
Price to Cash Flow (P/CF)-8.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue466.47
Enterprise Value/Gross Profit466.47
Enterprise Value/Ebitda-5.96
Forecast
1Y Price Target
€27.32Price Target Upside96.52% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Scholar Rock Holding News
PremiumPre-Earnings
Is SRRK a Buy, Before Earnings?
PremiumCompany Announcements
Scholar Rock Appoints New Director, Expands Board
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.28% Other Institutional Investors
99.72% Public Companies and
Individual Investors
2QK FAQ
What was Scholar Rock Holding Corp’s price range in the past 12 months?
Scholar Rock Holding Corp lowest stock price was €5.35 and its highest was €18.30 in the past 12 months.
What is Scholar Rock Holding Corp’s market cap?
Currently, no data Available
When is Scholar Rock Holding Corp’s upcoming earnings report date?
Scholar Rock Holding Corp’s upcoming earnings report date is May 09, 2024 which is in 3 days.
How were Scholar Rock Holding Corp’s earnings last quarter?
Scholar Rock Holding Corp released its earnings results on Mar 19, 2024. The company reported -€0.465 earnings per share for the quarter, missing the consensus estimate of -€0.435 by -€0.03.
Is Scholar Rock Holding Corp overvalued?
According to Wall Street analysts Scholar Rock Holding Corp’s price is currently Undervalued.
Does Scholar Rock Holding Corp pay dividends?
Scholar Rock Holding Corp does not currently pay dividends.
What is Scholar Rock Holding Corp’s EPS estimate?
Scholar Rock Holding Corp’s EPS estimate is -€0.45.
How many shares outstanding does Scholar Rock Holding Corp have?
Currently, no data Available
What happened to Scholar Rock Holding Corp’s price movement after its last earnings report?
Scholar Rock Holding Corp reported an EPS of -€0.465 in its last earnings report, missing expectations of -€0.435. Following the earnings report the stock price went down -7.752%.
Which hedge fund is a major shareholder of Scholar Rock Holding Corp?
Among the largest hedge funds holding Scholar Rock Holding Corp’s share is Woodline Partners LP. It holds Scholar Rock Holding Corp’s shares valued at 17M.
---
Scholar Rock Holding Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€27.32 (96.52% Upside)
€27.32 (96.52% Upside)
Blogger Sentiment
Bullish
DE:2QK Sentiment 100%
Sector Average 70%
Sector Average 70%
Technicals
SMA
Positive
20 days / 200 days
Momentum
110.56%
12-Months-Change
Fundamentals
Return on Equity
-68.30%
Trailing 12-Months
Asset Growth
-13.16%
Trailing 12-Months
Company Description
Scholar Rock Holding Corp
Scholar Rock Holding Corp. is a biopharmaceutical company, which engages in the development and discovery of innovative medicines. The company offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.
---
2QK Earnings Call
Q3 2023
0:00 / 0:00
---
2QK Stock 12 Months Forecast
Average Price Target
€27.32
▲(96.52% Upside)
Technical Analysis
Scholar Rock Holding
―
Rocket Pharmaceuticals
―
RegenXBio
―
Meiragtx Holdings
―
Crispr Therapeutics AG
―
Best Analysts Covering 2QK
1 Year
1 Year Success Rate
5/6 ratings generated profit
1 Year Average Return
+45.57%
reiterated a buy rating last month
Copying Srikripa Devarakonda's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +45.57% per trade.
---